![]()
|
|
||||||||
(Received for publication, October 3, 1996, and in revised form, January 14, 1997)
From the Department of Molecular, Cellular, and
Developmental Biology, University of California,
Santa Barbara, California 93106 and the ¶ Lilly Research
Laboratories, DC0520, Indianapolis, Indiana 46285
LY290181,
2-amino-4-(3-pyridyl)-4H-naphtho(1,2-b)pyran-3-carbonitrile,
is a potent antiproliferative compound that blocks cells in the
G2/M phase of the cell cycle by an apparent action on
microtubules. In the present work we found that LY290181 bound to
tubulin with high affinity (1 mol of LY290181 per mol of tubulin dimer;
Ka, 3.8 × 105
M
1) and that it did not appear to bind at the
colchicine or vinblastine-binding sites. LY290181 strongly stabilized
microtubule dynamics as determined by video microscopy. It reduced the
rate and extent of growing and shortening, reduced the catastrophe
frequency and increased the rescue frequency, and increased the
percentage of time the microtubules spent in an attenuated state. At
the lowest effective LY290181 concentrations (0.1-0.3
µM), suppression of dynamics occurred with little
reduction in polymer mass. However, at higher concentrations, LY290181
strongly reduced the polymer mass with half-maximal inhibition at a
concentration of 0.75 µM. We suggest that LY290181 may
exert its antiproliferative activity by stabilizing spindle microtubule
dynamics by binding to tubulin at a novel site.
This article has been cited by other articles:
![]() |
R. Aneja, S. N. Vangapandu, M. Lopus, R. Chandra, D. Panda, and H. C. Joshi Development of a Novel Nitro-Derivative of Noscapine for the Potential Treatment of Drug-Resistant Ovarian Cancer and T-Cell Lymphoma Mol. Pharmacol., June 1, 2006; 69(6): 1801 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jordan, K. Kamath, T. Manna, T. Okouneva, H. P. Miller, C. Davis, B. A. Littlefield, and L. Wilson The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth Mol. Cancer Ther., July 1, 2005; 4(7): 1086 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, K. Gupta, S. Aggarwal, R. Aneja, R. Chandra, D. Panda, and H. C. Joshi Brominated Derivatives of Noscapine Are Potent Microtubule-interfering Agents That Perturb Mitosis and Inhibit Cell Proliferation Mol. Pharmacol., April 1, 2003; 63(4): 799 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Panda, H. P. Miller, K. Islam, and L. Wilson Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: A possible mechanistic basis for its antitumor action PNAS, September 30, 1997; 94(20): 10560 - 10564. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Wood, D. Panda, T. R. Wiernicki, L. Wilson, M. A. Jordan, and J. P. Singh Inhibition of Mitosis and Microtubule Function through Direct Tubulin Binding by a Novel Antiproliferative Naphthopyran LY290181 Mol. Pharmacol., September 1, 1997; 52(3): 437 - 444. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |